特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

PharmSource:小分子API (医薬品原薬) の医薬品製造受託機関 (CMO)

PharmSource - Contract Small Molecule API Manufacturing Industry by the Numbers - 2019 Edition

発行 GlobalData 商品コード 912124
出版日 ページ情報 英文 44 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.98円で換算しております。
PharmSource:小分子API (医薬品原薬) の医薬品製造受託機関 (CMO) PharmSource - Contract Small Molecule API Manufacturing Industry by the Numbers - 2019 Edition
出版日: 2019年08月22日 ページ情報: 英文 44 Pages
概要

当レポートでは、世界の小分子API (医薬品原薬) 向け医薬品製造受託機関 (CMO) の業界構造について、企業数・施設数とその傾向の観点から分析し、市場参入企業の総数や、施設の種類別の傾向 - 規制薬物対応、封じ込め施設つきなど -、立地状況、大手企業の財務状況、事業展開・資本取引の動き (M&Aなど)、今後の市場発展の方向性、といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 表の一覧

第3章 図の一覧

第4章 エグゼクティブ・サマリー

第5章 業界の規模と構造

  • 小分子API (医薬品原薬) の医薬品製造受託機関 (CMO):定義
  • 業界構造:企業の特性別

第6章 大手CMOの小分子API製造施設の傾向

  • 規制薬物向け小分子API製造施設の動向
  • 封じ込め施設つき小分子API製造施設の動向

第7章 小分子API製造設備の立地傾向

  • 規制薬物製造施設の立地傾向
  • 封じ込め施設つき製造施設の立地傾向
  • 欧州市場の分析

第9章 企業合併・買収 (M&A) 活動:小分子API CMOが関係するもの

第10章 API CMO業界の将来展望

第11章 分析手法:注記

第12章 付録

図表

List of Tables

  • Table 1: Revenue Composition and Specialized Capabilities of Leading CMOs, 2018 25
  • Table 2: Percentage of Companies by Revenue Tier with Specialized Capabilities (Dedicated Contract and Public CMOs Only)
  • Table 3: CMO Small Molecule API Manufacturing Facility Acquisitions, 2015-2018 30
  • Table 4: CMO Small Molecule API Manufacturing Facilities Acquired by Company M&A and Divestment, 2015-2018 30
  • Table 5: CMO Small Molecule API Manufacturing Facilities Acquired by PE, 2015-2018 31
  • Table 6: Geographic Reach of CMOs with Small Molecule API Manufacturing, 2018 35
  • Table 7: Public CMOs' API Manufacturing Facilities and Controlled Substance/Containment Capabilities, 2018 40

List of Figures

  • Figure 1: Geographic Reach of the Small Molecule API CMO Universe, 2018 (Public CMOs Only) 7
  • Figure 2: Public CMOs with Small Molecule Manufacturing Capability by Annual Contract Revenue, 2018 8
  • Figure 3: Geographic Distribution by Headqua
目次
Product Code: GDPS0026MAR

This report characterizes the contract small molecule active pharmaceutical ingredient (API) manufacturing industry through a number of quantitative dimensions, including number and type of participants, containment and controlled substance capabilities, and financial performance of the top public contract manufacturing organizations (CMOs). Contract Small Molecule API Manufacturing is critical for establishing an understanding of the small molecule API CMO industry and the features of some of the largest CMOs participating in the industry.

Scope

Who should buy this report?

  • This 44-page report gives important, expert insight you won't find in any other source. 26 tables and figures throughout the report illustrate major points and trends. This report is required reading for:
  • CMO executives who must have deep understanding of the small molecule API marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to buy

  • Overview of contract small molecule API facilities and the proportion of containment and controlled substance specialist capabilities
  • Detailed view of the geographic distribution of the small molecule API facilities
  • Establishing which CMOs are most involved in contract small molecule API industry by facility count
  • Analysis of M&A activity related to small molecule API facilities

Table of Contents

1 Table of Contents

2 List of Tables

3 List of Figures

4 Executive Summary

5 Industry Size and Structure

  • 5.1 Definition of the Small Molecule API CMO Universe
  • 5.2 Industry Demographics

6 Top CMOs by Small Molecule API Facilities

  • 6.1 Controlled Substance Small Molecule API Manufacturing Facilities
  • 6.2 Small Molecule API Manufacturing Facilities with Containment

7 Geographical Distribution of Small Molecule Manufacturing Facilities

  • 7.1 Geographical Distribution of Controlled Substance Facilities
  • 7.2 Geographical Distribution of Facilities with Containment Capabilities
  • 7.3 European Analysis

8 Characteristics of the Largest CMOs

9 M&A Activity Involving Small Molecule Contract Manufacturing Facilities

10 The Outlook for the API CMO Industry

11 Notes on Methodology

12 Appendix

  • 12.1 Appendix Tables
  • 12.2 Bibliography
  • 12.3 Primary Research - Key Opinion Leaders in this Report
  • 12.4 About the Authors
  • 12.5 Contact Us
  • 12.6 Disclaimer